Company profile
Pharma-Bio Serv, Inc. CIK 1304161
Ticker
PBSV (OTC)
Industry
Services-Management Consulting Services
Headquarters
Dorado, PR 00646
Fiscal year end
2025 (FY)
Key Financials
Revenue
$9.00M
Net income
-$100.5K
Total assets
$13.65M
Total liabilities
$1.74M
Stockholders' equity
$11.91M
Cash & equivalents
$3.38M
Operating income
-$637.7K
Operating cash flow
-$214.9K
Capital expenditures
$6.6K
Fiscal year 2025, via 10-K filed 2026-01-29. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-7.1%
Net margin
-1.1%
Free cash flow
-$221.5K
Free cash flow margin
-2.5%
Liabilities / assets
12.7%
Equity / assets
87.3%
CapEx / revenue
0.1%
Operating cash flow / net income
2.14×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$9.00M
-$100.5K
$13.65M
$1.74M
$11.91M
2024
$9.51M
-$777.6K
$16.29M
$2.58M
$13.72M
2023
$16.98M
$1.31M
$19.90M
$3.78M
$16.13M
2022
$19.40M
$1.01M
$20.65M
$4.09M
$16.56M
2021
$20.12M
-$2.09M
$23.92M
$5.01M
$18.91M
Company Details
SIC code
8742
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-01-29
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Dorado, PR 00646
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:02 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.